A biotechnology company recently established a new Global Market Access team. To ensure their expertise was fully utilised by the parent company this team required support to:
Diagnostic interviews with company partner functions and selected affiliates.
Work closely with market access leadership team to establish guiding principles and value proposition.
Facilitate All-hands workshop to establish best ways of working.
Create information materials to be shared with partner functions.
Utilised off-shore resources to provide cost effective assistance in non-routine market access activities.
Budget and resource models were used to forecast increased FTEs and spend over 5 years.
Integrated unit with expertise in pricing, health economics and outcomes research, and country-specific reimbursement policy.
A well recognised ability to demonstrate product value by measuring the full picture of clinical, patient and economic outcomes for customers.
An overall increase in awareness and appreciation within the parent company regarding the value and utility of a global market access team.